NCT01538992

Renal Denervation in Patients With Advanced Heart Failure

Phase 3 Study of Renal Denervation That Improves Symptoms of Heart Failure and Enhances Life Quality in Advanced Heart Failure

• Status: Withdrawn
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Bursa Postgraduate Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

Sympathetic system has important role occurrence of symptoms in heart failure. Renal denervation that is ablated some of sympathetic nerves is affected pathology of heart failure. This interventional therapy improves symptoms and life quality.

Detailed description

Primary Outcome Measures: • Safety of Renal Denervation in Heart Failure patients as measured by Adverse Events Secondary Outcome Measures: • Ventricular function,NYHA functional Class, 6 min walking test, biochemical test and Renal function as measured by Glomerular Filtration Rate (GFR) Eligibility Patients population: Volunteers, NYHA Class III-IV heart failure patients. Ages Eligible for Study: 18 Years to 85 Years Genders Eligible for Study: Both Accepts Healthy Volunteers: No

Conditions

• Heart Failure

Interventions

Type	Name	Description
DEVICE	Standard steerable Marinr RF ablation Catheter (5F or 7F)	Intervention: Device: Standard steerable Mariner Radiofrequency ablation Catheter (5F or 7F)

Timeline

• Start date: 2013-04-01
• Primary completion: 2014-01-01
• Completion: 2014-04-01
• First posted: 2012-02-27
• Last updated: 2013-07-24

Locations

1 site across 1 country: Turkey (Türkiye)